Cottrell, E ORCID: https://orcid.org/0000-0002-5757-1854, Crabtree, V, Edwards, JJ and Roddy, E ORCID: https://orcid.org/0000-0001-8699-0735 (2013) Improvement in the management of gout is vital and overdue: an audit from a UK primary care medical practice. BMC Family Practice, 14. 170 - ?.

[img]
Preview
Text
Improvement in the management of gout is vital and overdue an audit from a UK primary care medical practice.pdf - Published Version
Available under License Creative Commons Attribution.

Download (470kB) | Preview

Abstract

BACKGROUND: Gout is estimated to affect 1.4% of adults in the UK. Appropriate and timely management is essential to reduce the risk of further flares, complications, and to reduce cardiovascular disease risk. The British Society for Rheumatology and British Health Professionals in Rheumatology (BSR/BHPR) and the European League Against Rheumatism (EULAR) have published guidance regarding the management of gout, thereby providing standards against which performance can be measured. This audit was designed to assess the extent to which patients diagnosed with gout in one primary care medical practice in North Staffordshire, UK, are managed in accordance with current best practice guidelines, and to identify strategies for improvement where appropriate. METHODS: Audit criteria were derived from the EULAR and BSR/BHPR guidelines; standards were set arbitrarily, but with consideration of patient comorbidity and other factors which may influence concordance. An electronic search of the practice records was performed to identify adults with a diagnosis of gout. Medical record review with a descriptive analysis was undertaken to assess the extent to which medical management adhered to the predefined standards. RESULTS: Of the total ≥18 year-old practice population (n = 8686), 305 (3%) patient records included a diagnosis of gout. Of these, 74% (n = 226) had an electronic record of serum uric acid (SUA), and 11% (n = 34) and 53% (n = 162) a measure of estimated glomerular filtration rate (eGFR) ever and serum glucose since diagnosis respectively. 34% (n = 105) of patients had ever taken urate-lowering therapy with 25% (n = 77) currently prescribed this at the time of data extraction. Dose adjustment and monitoring of treatment according to SUA was found to be inadequate. Provision of lifestyle advice and consideration of comorbidities was also lacking. CONCLUSIONS: The primary care management of gout in this practice was not concordant with national and international guidance, a finding consistent with previous studies. This demonstrates that the provision of guidelines alone is not sufficient to improve the quality of gout management and we identify possible strategies to increase guideline adherence.

Item Type: Article
Additional Information: This is the final published version (version of record). It was first published online via BioMed Central at https://doi.org/10.1186/1471-2296-14-170 - please refer to any applicable terms of use of the publisher.
Uncontrolled Keywords: Aged, Blood Glucose, Diet Therapy, Disease Management, Female, Glomerular Filtration Rate, Gout, Gout Suppressants, Guideline Adherence, Humans, Hyperuricemia, Kidney Function Tests, Male, Medical Audit, Middle Aged, Practice Guidelines as Topic, Primary Health Care, Quality Improvement, Retrospective Studies, Risk Reduction Behavior, United Kingdom, Uric Acid
Subjects: R Medicine > RC Internal medicine > RC925 Diseases of the musculoskeletal system
Divisions: Faculty of Medicine and Health Sciences > Primary Care Health Sciences
Related URLs:
Depositing User: Symplectic
Date Deposited: 05 Jun 2020 08:51
Last Modified: 05 Jun 2020 09:00
URI: https://eprints.keele.ac.uk/id/eprint/8110

Actions (login required)

View Item View Item